Episode 54: CRP – An important part of a Comprehensive Risk Profile or a Completely Ridiculous Practice- Part III
Episode 54 finishes off the whole issue of CRP measurement by looking at the evidence we have about what happens to patients when they take drugs that lower CRP – glitazones, COX-2s, fibrates, vitamin E, niacin, ezetimibe, and statins. Other than statins and maybe niacin, it doesn’t look good – in contrast to Mike and James of course that is.
Show Notes
1) Drugs that lower CRP
Cardiovasc Drug Rev 2006;24:33-50
Atherosclerosis 2005;179:361-7
2)Drugs that lower CRP and their effect on outcome
Glitazones
COX-2s
Fenofibrate
Bezafibrate
Vitamin E
Niacin
Ezetimibe
Statins
High dose statins – not treating to target
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
